ALGS · Categories · Form 3
ALGS - SEC Form 3 initial insider statements
Aligos Therapeutics Inc. (ALGS) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.
Recent Form 3 for ALGS
- SEC Form 3 filed by new insider Aneja Nikhil3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 3 filed by new insider Achneck Hardean3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 3 filed by new insider Chavez Margarita3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 3 filed by new insider Preston Heather3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- New insider Roche Holding Ltd claimed ownership of 11,025,941 shares (SEC Form 3)3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 3: New insider Mcclure Matthew W. claimed ownership of 91,204 shares3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 3 filed by new insider Martell Bridget A3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)
- SEC Form 3 filed by Scopa James Paul3 - Aligos Therapeutics, Inc. (0001799448) (Issuer)